Trials / Completed
CompletedNCT07012603
External Oblique and Rectus Abdominis Plane (EXORA) Block for Postoperative Analgesia in Patients Undergoing Umbilical Hernia Repair
External Oblique and Rectus Abdominis Plane (EXORA) Block for Postoperative Analgesia in Patients Undergoing Umbilical Hernia Repair: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effect of the external oblique and rectus abdominis plane (EXORA) block for postoperative analgesia in patients undergoing umbilical hernia repair.
Detailed description
Umbilical hernias account for approximately 6-14% of adult abdominal wall hernias. These hernias are typically acquired and are mainly caused by increased abdominal pressure. Umbilical hernias do not heal on their own and usually require surgical intervention. The external oblique and rectus abdominis plane (EXORA) block is an emerging technique providing a sensory block to the anterolateral abdominal wall. The EXORA block involves local anaesthetic injection into the fascial plane between the external oblique and rectus abdominis muscles. This method provides better dermatomal coverage, making the EXORA block particularly effective in the treatment of somatic pain in the anterolateral area of the upper and middle abdomen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | External oblique and rectus abdominis plane (EXORA) block | Patients will receive an external oblique and rectus abdominis plane (EXORA) block using 20 mL of bupivacaine 0.25%. |
| OTHER | Sham block | Patients will receive a sham block using 20 mL of normal saline as a control group. |
Timeline
- Start date
- 2025-06-10
- Primary completion
- 2026-02-03
- Completion
- 2026-02-03
- First posted
- 2025-06-10
- Last updated
- 2026-02-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07012603. Inclusion in this directory is not an endorsement.